project id: TCGA-COAD; case submitter id: TCGA-RU-A8FL; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 51; days to birth: -18975; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1960; age at diagnosis: 18975; ajcc pathologic m: MX; ajcc pathologic n: N2a; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1177.0; icd 10 code: C18.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cecum; synchronous malignancy: No; tissue or organ of origin: Cecum; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 861; initial weight: 130.0; sample id: 33754280-57c0-45b7-8f33-984ceb7ddffb; sample submitter id: TCGA-RU-A8FL-01A; portion id: adaff1ab-c04e-418e-b988-48f0cff3577c; portion submitter id: TCGA-RU-A8FL-01A-11; slide id: 3743238d-c8ae-49a3-b5c9-3b18c1b64964; slide submitter id: TCGA-RU-A8FL-01A-01-TSA; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 3.0; percent neutrophil infiltration: 0.0; percent normal cells: 7.0; percent stromal cells: 10.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;